HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

xanomeline

a cholinergic agonist; used in the treatment of Alzheimer's disease; structure given in first source
Also Known As:
(3-O-hexyloxy)-TZTP; 3-(3-O-hexyl-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine; LY 246708; LY-246708; LY246708; xanomeline tartrate
Networked: 36 relevant articles (10 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bymaster, Frank P: 3 articles (01/2012 - 04/2002)
2. McKinzie, David L: 2 articles (01/2012 - 08/2008)
3. Bymaster, F P: 2 articles (04/2001 - 05/2000)
4. Shannon, H E: 2 articles (04/2001 - 05/2000)
5. Pavlov, Valentin A: 1 article (02/2015)
6. Tracey, Kevin J: 1 article (02/2015)
7. Valdés-Ferrer, Sergio I: 1 article (02/2015)
8. Al-Abed, Yousef: 1 article (02/2015)
9. Ochani, Mahendar: 1 article (02/2015)
10. Rosas-Ballina, Mauricio: 1 article (02/2015)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Alzheimer Disease (Alzheimer's Disease)
3. Neurobehavioral Manifestations
4. Movement Disorders (Movement Disorder)
5. Sepsis (Septicemia)

Related Drugs and Biologics

1. Muscarinic Agonists
2. Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
3. cevimeline (Evoxac)
4. Lecithins
5. Cholinergic Agents (Cholinergics)
6. Trichlorfon (Metrifonate)
7. Tacrine (Cognex)
8. Scopolamine (Hyoscine)
9. Physostigmine
10. Galantamine (Galanthamine)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)
3. Analgesia